Clinical Trial Update: Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib mesylate combined with paclitaxel in older patients with stage IIIB or stage IV non-small cell lung cancer; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gleevec (Imatinib)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Washington | Conditions: Malignant Pleural Effusion, Recurrent Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-25